Puget Sound Drug Corporation dba Key Pharmacy and Compounding Center

CLOSEOUT LETTER Puget Sound Drug Corporation dba Key Pharmacy and Compounding Center MARCS-CMS 552431 — March 31, 2020 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: Via Email Product: Drugs Recipient: Recipient Name HeeJoo Park, RPh Recipient Title President and CEO, COO, CFO Puget Sound Drug Corporation dba Key Pharmacy and Compounding Center 530 South 336th Street Federal Way , WA 98003-6383 United States Issuing Office: Division of Pharmaceutical Quality Operations IV 19701 Fairchild Irvine , CA 92612-2506 United States 949-608-2900 Dear Ms. Park: The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our warning letter (WL# 552431) dated April 4, 2018. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter. You are expected to take all necessary steps to ensure compliance with the Federal Food, Drug, and Cosmetic Act and FDA’s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ CDR Steven E. Porter, Jr. Director, Division of Pharmaceutical Quality Operations IV Content current as of: 04/24/2020 Regulated Product(s) Drugs